TAK-411

N/A

Report date: 2025/02/28 10:45:30

Base Information

Drug NameTAK-411
Drug Alias NameHypersialylated Immune Globulin GTAK-411
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPolyradiculoneuropathy, Chronic Inflammatory Demyelinating
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesColombia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPolyradiculoneuropathy, Chronic Inflammatory Demyelinating
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A